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February 2010534 Abstractsstudies were designed to compare and contrast the influence of hypercho-
lesterolemia on the local and systemic inflammatory response to demand
ischemia (ie, exercise) in a murine model of vascular occlusive disease.
Methods: Apolipoprotein E/ (ApoE) and aged C57BL6 (C57)
mice underwent unilateral femoral artery ligation. At day 14, animals were
divided into sedentary and exercise groups. Basal hind limb and demand
ischemia was quantified using laser Doppler imaging. Neurologic function
was quantified using a standardized scale. Animals in the exercise groups
underwent daily treadmill exercise (15 m/min, 10° incline) on days 14
through 28. On day 28, serum and skeletal muscle from ischemic and
contralateral limbs were harvested immediately after exercise for measure-
ment of keratinocyte-derived chemokine (KC), vascular endothelial growth
factor (VEGF), interleukin (IL)-6, macrophage inflammatory protein
(MIP)-2, and histology.
Results: The degree of ischemia and neurologic function was similar
between groups before initiation of exercise. Under sedentary conditions,
compared with C57 mice, plasma VEGF and IL-6, but not KC or MIP-2
were higher in ApoE mice. After exercise, serum levels of VEGF, KC, and
MIP-2, but not IL-6, were lower in ApoE compared with C57 mice. Local
response to demand ischemia was higher in ApoE mice as measured by KC
levels. ApoE mice produced a significant increase in the percentage of
immature centrally nucleated skeletal muscle fibers under both sedentary
and demand conditions (Table).
Conclusion: In the setting of demand ischemia, the systemic inflam-
matory response is different in ApoE mice compared with C57 mice. The
altered inflammatory response to exercise in hypercholesterolemic mice may
play a role in postischemic skeletal muscle remodeling and mimic postisch-
emic muscle dysfunction in humans with claudication.
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Introduction: We performed a case-control comparison of long-term
results of femoral-popliteal bypass and superficial femoral artery (SFA)
endovascular interventions to examine characteristics of patients and proce-
dures to optimize results.
Methods: Femoral-popliteal bypasses and SFA interventions per-
formed for consecutive patients with symptoms (Rutherford 3 to 6) between
2001 and 2008 were reviewed. Time-dependent outcomes were assessed
with Kaplan-Meier survival analyses. Log-rank analyses, univariate, and
multivariate analyses were performed.
Results:During the study period, 152 limbs in 141 patients (66%male;
mean age, 66 22 years) underwent femoral-popliteal bypass; 233 limbs in
204 patients (49% male; mean age, 70  11 years) underwent SFA inter-
vention. Surgery was performed less commonly for claudication (46% vs
56%) and more commonly for critical ischemia (54% vs 44%). Six-year
primary, primary assisted, and secondary patency rates were 56%, 64%, and
75%, respectively, for bypass patients and 40%, 67%, and 85%, respectively,
for SFA interventions. Six-year limb salvage was 80% for surgery and 92% for
SFA interventions. Complications occurred in 21% of the surgery group and




ApoE/ C57RB P ApoE/ C57RB P
Plasma KC 227.8  95.2 301.3  29.8 NS 104.9  14 485.1  59.7 .0001
Plasma
IL-6
62.7  30 1.7  0.6 .0001 19.0  5.7 6.7  1.7 .05
Plasma
VEGF
258.4  13.4 78.2  7.8 .0001 167.2  15.6 245.0  25.0 .01
Plasma
MIP-2
20.4  8.1 14.6  2.1 NS 8.3  1.4 18.1  3.3 .01
Muscle KC 1.7  0.2 1.2  0.1 NS 2.8  0.4 1.8  0.2 .05
Muscle
IL-6




72.6  1.7 60.8  2.6 .001 77.2  4.3 56.3  5.5 .05
ApoE, Apolipoprotein E; IL, interleukin; KC, keratinocyte-derived chemo-
kine; MIP, macrophage inflammatory protein; VEGF, vascular endothelial
growth factor.in 1.2% of the endovascular group. Reintervention was required in 24% of
surgery patients and in 14% of endovascular patients. Failure of SFAintervention led to bypass in 5% of patients; however, prior failed
intervention did not change the target artery. Predictors of failure for
surgery and SFA interventions were female gender, diabetes, creatinine
1.8 mg/dL, and critical limb ischemia; however, limb salvage was no
different for all groups.
Conclusions: Although long-term patency and limb salvage were
equivalent, reinterventions and complications occurred at a higher rate in
the surgery group. Patients with critical limb ischemia, diabetes, or renal
failure had decreased patency with both treatments; however, limb salvage
was not disadvantaged for any group. SFA stent placement should therefore
be the initial therapy for patients with SFA occlusive disease.
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Introduction: Advances in endovascular techniques have provided
new options in the treatment of complex infrainguinal occlusive disease. This
study evaluated outcomes of endovascular interventions on TransAtlantic
Inter-Society Consensus (TASC II) D femoropopliteal lesions.
Methods: All patients undergoing endovascular interventions for fem-
oropopliteal occlusive disease between May 2003 and March 2009 were
included. Patient demographics, preprocedural and postprocedure ankle-
brachial indices (ABI), and anatomic factors were analyzed.
Results: During the period reviewed, 455 limbs were treated. The
study group included 75 TASCD limbs in 70 patients (59% men; mean age,
74.8 11.9 years). Fifty-three limbs (71%) underwent treatment for critical
limb ischemia, including 40 (53%) with tissue loss; 29% were treated for
lifestyle-limiting claudication. Eleven (15%) had previous failed bypasses.
Preoperative ABIs could not be obtained in 20 patients because of noncom-
pressible vessels. The remaining 55 had a mean baseline ABI of 0.56 0.21.
No procedurally related deaths or major complications occurred. Mean
increase in ABI postprocedure was 0.52  0.28. Mean follow-up of 9.0
months (range, 1-25 months) was available for 65 limbs, during which 17
(21%) underwent successful reintervention for restenosis. Occlusion oc-
curred in six limbs (8%): three were revascularized with an endovascular
intervention, and three remained asymptomatic and were managed conser-
vatively. Proximal trifurcation involvement (P .95) and the presence of less
than two tibial runoff vessels (P .87) were not associated with a higher risk
of restenosis or occlusion. The primary patency rate was 77%, the primary
assisted patency was 92%, and the secondary patency rate was 96%. Limb
salvage was achieved in all patients treated for critical limb ischemia.
Conclusions:Endovascular interventions for TASC II D lesions can be
safely performed with excellent hemodynamic improvement and limb sal-
vage rates. Restenosis is not uncommon in this population, which mandates
strict surveillance. Further follow-up is necessary to determine the long-term
efficacy of these interventions.
Standardized Techniques for Percutaneous Treatment of Superficial
Femoral Artery-Popliteal TransAtlantic Inter-Society Consensus C and
D Lesions Improve Outcomes: Midterm Analysis of a Prospective
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Purpose: To better understand the implications of the percutaneous
superficial femoral artery (SFA)-popliteal procedure techniques, we com-
pared the patency of treating TransAtlantic Inter-Society Consensus
(TASC) C and D lesions by using a standardized vs a nonstandardized
approach.
Methods: From 2004-2008, 352 patients with symptomatic infrain-
guinal SFA-popliteal TASC C and D lesions undergoing angioplasty and
routine stenting were divided into groups according to technique. The
standardized technique was used in 173 (49%) and the nonstandardized in
179 (51%). The standardized technique included (1) initial subintimal
angioplasty at higher balloon pressures (20-25 atm), (2) 20% balloon
oversizing, (3) stent placement after angioplasty, (4) minimum stent overlap
of1 cm, and (5) treatment of moderate and severe SFA-popliteal occlusive
disease. The nonstandardized technique included most routine approaches
currently used, not adhering to standardization. Patients were monitored at
1-, 3-, and 6-month intervals with duplex ultrasound imaging, peripheral
vascular resistance measurements, and clinical examination. The Society for
Vascular Surgery criterion was used to define patency failure.
Results: The standardized technique group had significantly higher
American Society of Anesthesiologists classification of III to IV (77% vs 49%,
P  .05), longer mean lesion lengths (26.5 vs 16.1 cm, P  .05), and a
